Delivery Order SPE2DB22D1017-SPE2DB24FF8DH
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of OxyContin ER 10 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,095.66 and a performance period through May 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,850,528 Oxycontin ER 10 mg tablets in 100-count bottles. The $1,377.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024, with a completion date of June 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of OxyContin ER 20 mg tablets. The contract is a Delivery Order valued at $1,941.97 with a firm fixed price and a completion date of March 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award is for the delivery of 4,565,159,801 units of OxyContin ER 40mg tablets in 100-count bottles to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The firm-fixed-price contract, valued at $2,501.06, was awarded on July 15, 2024 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of July 16, 2024 and does not have a set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Oxycontin ER 60 mg tablets. The contract, valued at $5,929.74, has an ultimate completion date of August 28, 2023 and was awarded on August 25, 2023 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order under a Firm Fixed Price type and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corporation's Corporate Office division. The $6,079.69 fixed-price delivery order is for the supply of 4,564,886,225 tablets of the prescription opioid medication OxyContin ER 60 mg. The contract has a completion date of June 13, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a...
- This federal contract award, valued at $1,198.23, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OxyContin ER 20 mg tablets, a branded prescription medication, to support the Department of Defense's medical treatment programs and facilities worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,059,472 OxyContin ER 40 mg tablets in 100-count packages. The $2,444.93 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on July 2, 2024, with a completion date of July 3, 2024. This award is made under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for Oxycontin ER 40 mg tablets. The $1,606.68 firm fixed price contract has a completion date of July 7, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows Amerisourcebergen to supply...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,522.14 for the supply of Oxycontin ER 20 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of March 10, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF8DHDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OxyContin ER 10 mg tablets in 100-count bottles. The contract, valued at $1,223.67, was awarded on May 22, 2024 by the Defense Logistics Agency, a component of the Department of Defense, with a performance period ending on May 23, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/22/24 |